Objective: The objective of this study was to evaluate the results of salvage surgery after definitive chemoradiation for hypopharyngeal squamous cell carcinoma. Methods: This was a retrospective cohort study. Of the 79 patients with previously untreated hypopharyngeal squamous cell carcinoma who received definitive chemoradiation from January 2004 to January 2009, 24 who had recurrence and underwent salvage surgery at the National Cancer Center Hospital East, Chiba, Japan, were enrolled in this study. Results: Of the 24 patients who underwent salvage surgery with curative intent, 13 had an isolated local failure, eight had an isolated neck failure and three had combined local and regional failure. Postoperative surgical complications were observed in eight (33.3%) patients. Of the 24 patients undergoing salvage surgery, 12 (50%) had recurrence. In 11 of these patients, death ensued from salvage failure, defined as the presence of any recurrence after salvage treatment. The causes of cancer-specific death ensuing from salvage failure were regional recurrence of the tumor (n ¼ 6) (one of whom had concurrent distant metastases) and distant metastases alone (n ¼ 5). No local recurrence after salvage surgery was observed in our group of patients. The disease-free and overall 24-month survival rates were 49.0 and 50.0%, respectively. Those patients who initially presented with unresectable disease had lower overall survival compared with those who initially presented with resectable disease (P ¼ 0.0003). Conclusions: The oncologic outcomes were acceptable in those patients in whom salvage surgery was carried out. Those who initially presented with unresectable disease had a poor prognosis.
INTRODUCTION
Chemoradiation therapy (CRT) has become one of the standard treatments for advanced-stage head and neck squamous cell carcinoma (HNSCC) in recent years (1) (2) (3) . Meta-analyses show that CRT improves survival rate compared with radiotherapy alone (4, 5) .
With the general use of CRT, surgery has increasingly been reserved as a salvage treatment in cases of locoregional failure. However, the higher rates of acute and long-term toxicity after CRT can result in higher rates of postoperative morbidity and mortality (6 -8) , which may limit the potential benefit of salvage surgery. Further review of the results and complications of salvage surgery after locoregional failure in patients treated with CRT is, therefore, important. Although organ preservation by means of CRT is gaining popularity, few studies have specifically analyzed the results of salvage surgery in cases of failure after CRT (7 -10) , and even fewer studies have focused on salvage surgery for hypopharyngeal squamous cell carcinoma (HPSCC) (11, 12) .
HPSCC often presents with an advanced primary tumor and is associated with early nodal metastasis. HPSCC has one of the worst prognoses of all head and neck tumors and a low survival rate, making the choice of treatment difficult. Salvage surgery after CRT for patients with HPSCC is challenging because of the associated morbidity/mortality and the poor prognoses for these patients (11, 12) .
The objective of this study was to review our experience of patients with locoregional HPSCC who failed primary CRT intended for cure and underwent attempted surgical salvage.
PATIENTS AND METHODS
This was a retrospective cohort study. Of 79 patients with HPSCC who received primary chemoradiation intended for cure from January 2004 to January 2009, 24 who experienced recurrence and underwent attempted salvage surgery at the National Cancer Center Hospital East, Chiba, Japan, were enrolled in this study.
Only patients with newly diagnosed, biopsy-proven SCC were included, with those undergoing prior surgery in the targeted neck excluded. At our hospital, treatment planning was performed in a multidisciplinary oncology forum. All the patients underwent computed tomography (CT) and Magnetic resonance imaging (MRI) before treatment. The criteria for unresectability were as follows: (i) T4b disease or a tumor so extensive that resection would preclude functional reconstruction and (ii) unilateral neck node metastases fixed to the carotid artery, mastoid, base of skull or cervical spine.
The post-treatment imaging modality was CT and MRI with or without positron emission tomography (PET). Post-treatment imaging protocols were performed 6 to 8 weeks post-treatment, and the post-treatment scans were carefully reviewed in conjunction with the head and neck radiologist. Patients were followed up every month during the first year, every 2 months up to 2 years, every three months up to 3 years and then every 4 to 6 months up to 5 years. Patients who displayed clinical evidence of persistent primary or nodal disease, based on physical evaluation, CT, MRI or PET, underwent surgery.
Oncologic outcomes were determined by calculating the overall and disease-free survival from the time of surgery to the time of death for patients who underwent salvage surgery. JMPw 9 (SAS Institute Inc., Cary, NC, USA) was used to perform Kaplan -Meier survival analyses. Log-rank tests were performed with JMPw9 to assess correlations among survivor functions and to obtain associated P values.
RESULTS
From January 2004 to January 2009, 79 consecutive patients with HPSCC received platinum-based CRT as first-line treatment with curative intent. Fifty-eight of these 79 patients initially presented with resectable tumors. The remaining 21 patients initially presented with unresectable tumors.
Among the 58 patients with resectable tumors, 22 had persistent disease or recurrences with local or regional failures without distant metastasis. Of these 22 patients, 19 (86.4%) underwent attempted salvage surgery. On the other hand, among the 21 patients with unresectable tumors, 11 had persistent disease or recurrences with local or regional failures without distant metastasis. Of these 11 patients, 5 (45.5%) underwent attempted salvage surgery (Fig. 1) . All the nine patients from the two groups who had locoregional failures but did not undergo salvage surgery died with disease. The median survival after the day of recurrence was 2 months (range 0 -13 months) in these patients.
Of the 24 patients who underwent salvage surgery with curative intent, 13 had an isolated local failure, 8 had an isolated neck failure and 3 had combined local and regional failure. Table 1 shows the clinical characteristics of the patients with a local and/or regional failure. All the 24 patients had received a course of radiotherapy (RT) at 60 to 70 Gy delivered either by a conventional or by an accelerated fractionation regimen. Eight The median disease-free period after CRT in these 24 patients was 5 months. Fourteen patients (58.3%) had persistent disease, defined as treatment failure followed by salvage surgery within 6 months of completing CRT. The remaining 10 patients (41.7%) had recurrent disease following CRT, defined as treatment failure followed by salvage surgery occurring at a time .6 months of completing CRT (range 6.3 -51 months). Following the failure of CRT, salvage surgery was performed at the primary site alone (n ¼ 7), at the primary site with a ND (n ¼ 9) or as a ND alone (n ¼ 8). There were 15 cases of total laryngo-pharyngo-esophagectomy (TPLE) with free jejunum transfer (FJT) and one case of total laryngectomy (Table 2) .
No postoperative mortality was observed in our group of patients; however, postoperative surgical complications were observed in eight patients (33.3%). Surgical morbidities included total necrosis of the transferred jejunum (n ¼ 1), pharyngocutaneous fistula (n ¼ 1), tracheostomal necrosis (n ¼ 3), tracheostomal stenosis (n ¼ 1), lymphorrhea and cervical skin necrosis (n ¼ 1) and hematoma (n ¼ 1). Surgical complications were observed in four of the six patients in the accelerated RT/FP group, which was a significantly higher rate (P ¼ 0.046) than that observed in the other groups (4 of 18 patients). Those for which treatment involved excisions of the primary tumor showed a higher rate of postoperative surgical complications compared with those without resection of the primary tumor (43.8 versus 12.5%), although the differences were not significant (P ¼ 0.19) (see Table 3 ). There was also a slight trend toward an increase in the frequency of postoperative complications when salvage surgery was carried out ,6 months after the completion of CRT treatment (persistent disease 43.9% versus recurrent disease 20.0%) (P ¼ 0.39). 1212 Salvage surgery after CRT for HPSCC
The mean and median follow-up times after salvage surgery were 25 and 23 months, respectively (range 3 -67 months). Of the 24 patients who underwent salvage surgery, 12 (50.0%) had recurrence. Further, 13 of the 24 patients treated with salvage surgery died. In 11 of these patients, death ensued from salvage failure, defined as the presence of any recurrence after salvage treatment, and 2 patients died from causes unrelated to hypopharyngeal cancer. The causes of cancer-specific death ensuing from salvage failure were regional recurrence of the tumor (n ¼ 6) (one of whom had concurrent distant metastases), or distant metastases alone (n ¼ 5). No local recurrence after salvage surgery was observed in this study, although we were not able to achieve microscopically clear resection margins in 2 (12.5%) of the 16 patients who underwent excisions of local tumors. No additional post-surgical treatment was performed for the two patients who underwent incomplete resection, one of whom experienced regional recurrence and died at 20 months postsurgery. The other patient was initially staged as T4b and received CRT; however, the patient committed suicide at 10 months after salvage surgery.
The overall 24-month survival rate was 50.0% (Fig. 2) . The disease-free 24-month survival rate was 49.0%. The 2-year locoregional control was 67.6%. Those who initially presented with unresectable disease had lower overall survival in comparison with those who initially presented with resectable disease. Overall survival rates at 2 years for these patients were 0 and 63.2%, respectively (P ¼ 0.0003) (Fig. 3) . All of the five patients with initial unresectable disease died. The causes of salvage failures in these patients were regional recurrence alone (n ¼ 2), distant metastases alone (n ¼ 1) and concurrent regional and distant metastases (n ¼ 1). The one patient with incomplete resection died by suicide 10 months after surgery as described above. The 2-year survival rates for the CDDP, FP or S-1/CDDP, and accelerated RT/FP groups were 37.5, 30.0 and 100%, respectively (Fig. 4) . The prognosis for the accelerated RT/FP group was significantly better than those for the other groups (2-year OS 100 versus 33.3%) (P ¼ 0.0081). Those who initially presented with T4 disease, node-positive disease, recurrent disease (interval between CRT and salvage surgery was 6 months) or pathological T4 disease had lower overall survival, although the differences were not significant (P ¼ 0.05, 0.26, 0.17 and 0.05, respectively). There were no significant differences in survival in patients with or without resection of the primary tumor (P ¼ 0.99). In addition, pathological node-positive disease was not associated with decreased survival (P ¼ 0.90) ( Table 4) .
DISCUSSION
Salvage surgery is the only curative treatment for most patients who have failed CRT. Despite the general use of CRT, few studies have specifically analyzed the results of salvage surgery in cases of failure after CRT (7 -10), and even fewer studies have focused on salvage surgery for HPSCC (11, 12) . HPSCC has one of the worst prognoses of all head and neck squamous cell carcinomas and a low survival rate, making the choice of treatment difficult. Recent changes in CRT have contributed to improvements in functional organ preservation, but successful locoregional control does not always increase survival rates. It has been reported that the feasibility of salvage therapies following tumor recurrence is generally low (7, 11, 13) .
Our study is distinguished from these retrospective cohort studies by our focused clinical question addressing surgical salvage efficacy in hypopharyngeal cancer patients after failure of primary CRT, and by our inclusion of patients who initially presented with an unresectable tumor carrying a poor prognosis.
The first point to consider is that after failure of the CRT, a certain proportion of patients are not considered candidates for salvage treatment. Of our patients who had locoregional failures without distant metastasis, 27.3% (9 of 33) could not have salvage surgery and died as a consequence of disease progression within a median period of 2 months. A higher proportion of patients with initially resectable tumors had salvage surgery than did patients with unresectable tumors. A total of 86.4% (19 of 22) of our patients with initially resectable tumors were considered candidates for salvage surgery, while 45.5% (5 of 11) of patients with unresectable tumors had salvage surgery. Three of the 22 patients with initially resectable tumors who had locoregional failures could not receive salvage surgery because of unresectable regional recurrence. It is probable that these three patients should have been initially treated with surgery, but they were initially treated with CRT because they strongly desired organ preservation therapy. Incidentally, patients were generally considered contraindicating an organ-preserving approach in our institute if they presented with resectable primary tumors showing endophytic and ulcerative growth patterns associated with marked destruction of the thyroid cartilage and/or airway stenosis requiring tracheostomy, unless they refused mutilating surgery.
Recurrent tumors are often understaged by clinical examination and imaging studies, with a tendency to appear as multicentric tumor foci around the primary tumor location (14) . Additionally, the diagnosis of recurrence is delayed by the edema occurring after irradiation. This means that wide resection and some extensive reconstruction are often needed for local failures. Considering the poor overall survival for salvage surgery in advanced HPSCC, a TPLE with FJT must be considered the main procedure for failure after CRT. Therefore, the indication of partial laryngo-pharyngectomy for local failure should be strictly limited. As a rule, we do not perform partial laryngo-pharyngectomy against recurrent or persistent HPSCC after definitive CRT. In our study, total laryngectomy was indicated in one case, with TPLE and FJT indicated in all other cases. Relic et al. (12) reported that total laryngectomy appeared to be necessary in 15 of 16 cases, while transoral lasersurgical partial laryngectomy was indicated for the local recurrence of laryngeal and 
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Salvage surgery after CRT for HPSCC hypopharyngeal carcinoma in the remaining case. The rate of positive resection margins was reported to be as high as 40% in salvage surgery (15, 16) . Despite the care taken in ensuring large margins during surgery, we were not able to achieve microscopically clear resection margins in 12.5% of the patients who underwent excision of local tumors. This underlines the difficulty in attaining R0 resections in salvage surgery after CRT. The indication for salvage ND has been controversial (17) . The main problem is the difficulty in distinguishing scarred lymph node tissue from nodes containing vital tumor cells. Fine needle aspiration cytology or open biopsy can provide false-negative results as vital tumor tissue may not be present in all parts of the lymph node. PET does not yet seem to offer a solution to this problem (18, 19) .
In the presence of persistent or recurrent isolated neck metastases after initial radiotherapy of advanced laryngeal and hypopharyngeal SCC, an ND is predominantly indicated in the literature (20, 21) . ND seems to be inappropriate if no vital tumor tissue is detected after excision of suspicious residual nodes. Some authors, therefore, advocate a 'watch-and-see' policy for persistent lymph nodes in HNSCC as long as a decrease in size can be demonstrated after CRT (22) . Others are in favor of an immediate ND after CRT for all patients with initial N2/N3 (23 -25) or only in N3 (19) neck disease, even in the presence of complete response. Robbins et al. (26) proposed superselective ND (for two or fewer neck levels) for selected patients with persistent lymph node disease after CRT for advanced HNSCC. They found that locoregional disease control and survival among patients who underwent selective and superselective ND did not differ significantly from those among patients who underwent a more radical approach.
We have also performed so-called superselective ND for patients showing clinical evidence of residual adenopathy confined to a single neck level as determined by CT imaging and physical examination findings. As a rule, we did not perform ND in the presence of complete response even after extended initial neck disease.
This approach allows the minimization of complications while avoiding the creation of dead space. Dysfunction after ND may decrease, and patients' quality of life may improve with this approach. Further studies are needed to determine whether this approach results in better disease control in the neck than more traditional neck surgery.
It is well known that major wound complications after head and neck surgery increase in patients receiving RT (27, 28) . The addition of concurrent chemotherapy to RT increases tissue damage and impairs nutritional status, which are generally believed to lead to poor wound healing and higher rates of postoperative complications (8,29 -31) . Several authors have reported complication rates associated with surgical salvage following all forms of organ-preserving treatment for HNSCC of 46 to 61% (27, 32, 33) . In these previous studies, major complications occurred more often with surgery at the primary site than in NDs, with pharyngocutaneous fistulas and wound breakdown being the most common morbidities. Other studies have shown that pharyngocutaneous fistulas occur more often in patients with a short interval between the completion of radiotherapy and salvage surgery (34, 35) .
The surgical morbidity rate in our study was 33%. In our cohort, the variables related to the appearance of postoperative complications were resection of the primary tumor and an interval between CRT and salvage surgery of ,6 months, although the difference was not significant. Miyamoto et al. (31) reported the safety and efficacy of TPLE and FJT after RT or CRT for HPSCC in our institute. The authors concluded that TPLE and FJT can be safely performed, even in patients who have received RT, with acceptable rates of morbidity and mortality. In salvage TPLE after CRT, we usually elevate a skin flap under the superficial cervical membrane for preserving blood flow to the cervical skin. We also take a longer-than-usual free jejunum and fill the dead space with mesentery to prevent surgical complications. Our patients who did not routinely receive RT started oral feeding 1 week after TPLE and FJT. However, for patients who have received RT, oral feeding was withheld for at least 2 weeks. The effect of delayed feeding on fistula formation is controversial and its rationale is unclear (36, 37) . We believe that wound healing has progressed sufficiently by 2 weeks, not only at the mucosal suture lines but also around the major vessels, and therefore, the resulting damage would be localized even if pharyngocutaneous fistula developed.
The patients in our study had predominantly advanced HPSCC, with all but two patients having Stage III or IV disease at initial presentation. The 2-year overall survival after salvage surgery (50.0%) compared favorably with the 2-year overall survival (26.7%) reported in a retrospective series of patients who had failed CRT with curative intent (7). The disease-free 2-year survival in our group of patients was 49.0%, while the 2-year locoregional control was 67.6%. Patients who initially presented with an unresectable tumor had poor outcomes following salvage surgery. A comparison of CRT by intensity reveals that the accelerated RT/FP group had a significantly better prognosis than the other groups (2-year OS 100 versus 33.3%). Kawashima et al. (38, 39) reported the feasibility and efficacy of chemotherapy-enhanced accelerated RT for intermediate-volume HPSCC in our institute. The authors reported that the overall survival and local control rates at 3 years were 91 and 88%, respectively. In the present study, two patients initially staged as II and one patient staged as III were included in the accelerated RT/FP group. One reason for the better overall survival of the accelerated RT/FP group was that the proportion of patients with a favorable stage in that group was higher than those in the other groups. The rate of postoperative surgical complications was significantly higher in the accelerated RT/FP group. This result suggests that chemotherapy-enhanced accelerated RT is no less aggressive than intensive concurrent CRT.
The largest meta-analysis of salvage surgery efficacy to date reviewed 32 studies involving HNSCC patients who had received any form of attempted organ-preserving treatment Jpn J Clin Oncol 2013;43 (12) 1215 prior to undergoing surgery (32) . The overall median survival was 21.5 months, and the overall weighted average of 3-year survival rates was 37%. In this meta-analysis, if only the patients with Stage III and IV disease are considered, the 2-year disease-free survival was 33 and 22%, respectively. Several authors have reported some prognostic factors after salvage surgery. Richey et al. (7) reported that initial N3 staging correlated with poorer outcomes in patients who had salvage surgery after failed CRT with curative intent. Tan et al. (9) reported that initial Stage IV tumors and concurrent local and regional failure appeared as independent predictors for decreased survival after salvage surgery. The poor outcomes among our nine patients who had locoregional failures but could not have salvage surgery (the median survival was 2 months; range 0 -13 months) would suggest that salvage surgery, where feasible, offers the only real chance for securing long-term survival. Our mean and median follow-up periods of 25 and 23 months seem short; however, long-term follow-up is difficult to achieve in a population with a median survival of 21 months. Prospective data with a longer follow-up are needed for this specific population.
CONCLUSION
This analysis of retrospectively collected data of 24 patients who had failure of CRT for HPSCC demonstrated that salvage surgery has acceptable outcomes. Those who initially presented with unresectable disease had a poor prognosis. Clinicians have to balance the possible gains of those patients who can be successfully salvaged against the potential harm to those who fail salvage surgery.
